Department of Pharmacology, Government Medical College, Nagpur, Maharashtra, India.
Indian J Pharmacol. 2012 Jul-Aug;44(4):475-9. doi: 10.4103/0253-7613.99311.
The aim of this study is to evaluate the analgesic and anti-inflammatory activities of atorvastatin and simvastatin in different experimental models in mice and rats.
Analgesic activity of simvastatin and atorvastatin was assessed in tail flick model in rats (n = 6), where it was compared with aspirin and tramadol and in acetic acid induced writhing in mice (n = 6), where it was compared with aspirin. Anti-inflammatory activity of statins was evaluated using carrageenin induced paw edema and formalin induced arthritis in rats.
In the tail flick method, analgesic effect of tramadol was significantly more than the other drugs except at two observation times, when it was comparable to simvastatin and atorvastatin. Effect of simvastatin was found to be comparable to aspirin. In acetic acid induced writhing method, analgesic activity of simvastatin was comparable to that of aspirin while that of atorvastatin was significantly less. In carrageenin induced paw edema in rats, both simvastatin and atorvastatin showed anti-inflammatory activity which was comparable to aspirin. Both the statins exhibited significant anti-inflammatory activity (P < 0.01) in formalin induced arthritis model though less than aspirin (P < 0.05).
The results of this study if substantiated by further experimental and clinical research suggest that simvastatin and atorvastatin may play an adjuvant role, which may be particularly beneficial in the treatment of inflammatory disorders, especially when there is coexisting dyslipidemia.
本研究旨在评估阿托伐他汀和辛伐他汀在不同实验模型中对小鼠和大鼠的镇痛和抗炎作用。
采用大鼠尾缩法(n=6)评估辛伐他汀和阿托伐他汀的镇痛活性,与阿司匹林和曲马多进行比较;采用醋酸诱导扭体法(n=6)在小鼠中评估辛伐他汀和阿托伐他汀的镇痛活性,与阿司匹林进行比较。采用角叉菜胶诱导的大鼠足肿胀和甲醛诱导的关节炎评估他汀类药物的抗炎活性。
在尾缩法中,曲马多的镇痛作用明显强于其他药物,但在两个观察时间点除外,此时与辛伐他汀和阿托伐他汀相当。辛伐他汀的作用与阿司匹林相当。在醋酸诱导的扭体法中,辛伐他汀的镇痛活性与阿司匹林相当,而阿托伐他汀的镇痛活性显著较低。在角叉菜胶诱导的大鼠足肿胀中,辛伐他汀和阿托伐他汀均表现出抗炎活性,与阿司匹林相当。两种他汀类药物在甲醛诱导的关节炎模型中均表现出显著的抗炎活性(P<0.01),尽管低于阿司匹林(P<0.05)。
如果进一步的实验和临床研究证实这些结果,那么辛伐他汀和阿托伐他汀可能发挥辅助作用,特别是在治疗炎症性疾病时,尤其是在存在血脂异常的情况下,可能特别有益。